Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein Structure.
Krámos B, Hadady Z, Makó A, Szántó G, Felföldi N, Magdó I, Bobok AÁ, Bata I, Román V, Visegrády A, Keserű GM, Greiner I, Éles J. Krámos B, et al. Among authors: bata i. ACS Med Chem Lett. 2024 Mar 1;15(3):396-405. doi: 10.1021/acsmedchemlett.3c00560. eCollection 2024 Mar 14. ACS Med Chem Lett. 2024. PMID: 38505850
Optimization of Novel α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560).
Ledneczki I, Némethy Z, Molnár KD, Tapolcsányi P, Ilkei V, Vágó I, Kolok S, Thán M, Laszy J, Balázs O, Krámos B, Szigetvári Á, Bata I, Makó A, Visegrády A, Fodor L, Vastag M, Lévay G, Lendvai B, Greiner I, Éles J. Ledneczki I, et al. Among authors: bata i. J Med Chem. 2023 Dec 14;66(23):16276-16302. doi: 10.1021/acs.jmedchem.3c01635. Epub 2023 Nov 21. J Med Chem. 2023. PMID: 37989278
Synthesis and Characterization of New V1A Antagonist Compounds: The Separation of Four Atropisomeric Stereoisomers.
Szeleczky Z, Szakács Z, Bozó É, Baska F, Vukics K, Lévai S, Temesvári K, Vass E, Béni Z, Krámos B, Magdó I, Szántay C Jr, Kóti J, Domány-Kovács K, Greiner I, Bata I. Szeleczky Z, et al. Among authors: bata i. J Med Chem. 2021 Jul 22;64(14):10445-10468. doi: 10.1021/acs.jmedchem.1c00863. Epub 2021 Jul 13. J Med Chem. 2021. PMID: 34255509
Multiparameter Optimization of Naphthyridine Derivatives as Selective α5-GABAA Receptor Negative Allosteric Modulators.
Szabó G, Éliás O, Erdélyi P, Potor A, Túrós GI, Károlyi BI, Varró G, Vaskó ÁG, Bata I, Kapus GL, Dohányos Z, Bobok AÁ, Fodor L, Thán M, Vastag M, Komlódi Z, Soukupné Kedves RÉ, Makó É, Süveges B, Greiner I. Szabó G, et al. Among authors: bata i. J Med Chem. 2022 Jun 9;65(11):7876-7895. doi: 10.1021/acs.jmedchem.2c00414. Epub 2022 May 18. J Med Chem. 2022. PMID: 35584373
Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist.
Baska F, Bozó É, Szeleczky Z, Szántó G, Vukics K, Szakács Z, Domány-Kovács K, Kurkó D, Vass E, Thán M, Vastag M, Temesvári K, Lévai S, Halász AS, Szondiné Kordás K, Román V, Greiner I, Bata I. Baska F, et al. Among authors: bata i. J Med Chem. 2024 Jan 11;67(1):643-673. doi: 10.1021/acs.jmedchem.3c01868. Epub 2024 Jan 2. J Med Chem. 2024. PMID: 38165765
Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists.
Baska F, Szántó G, Bozó É, Szakács Z, Dékány M, Szondiné Kordás K, Domány-Kovács K, Kurkó D, Hodoscsek B, Magdó I, Krámos B, Béni Z, Vastag M, Bata I. Baska F, et al. Among authors: bata i. ACS Chem Neurosci. 2020 Nov 4;11(21):3532-3540. doi: 10.1021/acschemneuro.0c00486. Epub 2020 Oct 21. ACS Chem Neurosci. 2020. PMID: 33084311
92 results